Skip to main content
. 2009 Jul 7;2:29. doi: 10.1186/1756-3305-2-29

Figure 1.

Figure 1

Chemical structure of bortezomib. Bortezomib ([(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid) is marketed as Velcade® by Millennium Pharmaceuticals and currently used to treat people with multiple myeloma.